Biologics Safety Testing Market Comprehensive Report on Major Application Therapeutics and Diagnostics Treatment and Management Scope: Market Research Future Details
Global Biologics Safety Testing Market is expected to grow significantly over the forecast period. The market held a market value of USD 2.79 billion in 2017 and is projected to register a CAGR of 13.6% over the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure that the product is safe and free of contaminants. Recently, CDER approved 46 novel drugs in 2017, whereas 22 in 2016.
View full press release